2006
DOI: 10.1139/v06-078
|View full text |Cite
|
Sign up to set email alerts
|

Cyclotrimerization approach to unnatural structural modifications of pancratistatin and other amaryllidaceae constituents — Synthesis and biological evaluation

Abstract: The phenanthridone core of pancratistatin lacking all aromatic oxygenation was prepared by cyclotrimerization of acetylene-containing scaffolds 30 and 41, reflecting the natural and the C-1 epi configuration, respectively, of the amino inositol moiety. The cobalt-catalyzed formation of the aromatic core led to bisTMS derivatives 39 and 48, as well as bisacetyl derivative 51. The effectiveness of cyclotrimerization of the natural or trans series was compared with that of the cis series. In addition, the yields … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 34 publications
(16 citation statements)
references
References 20 publications
1
15
0
Order By: Relevance
“…10 times less potent than its 7-hydroxy congener. 137 Recently, Pandey and coworkers reported the results of investigations of the effects of pancratistatin on normal and cancer cells, providing evidence supporting selective toxicity of this isocarbostyril to cancer cells. Thus, pancratistatin was found to selectively induce apoptosis using non-genomic targets in Jurkat (model for human T-cell leukemia) cell line as opposed to normal nucleated blood cells.…”
Section: Anticancer Activitiesmentioning
confidence: 99%
“…10 times less potent than its 7-hydroxy congener. 137 Recently, Pandey and coworkers reported the results of investigations of the effects of pancratistatin on normal and cancer cells, providing evidence supporting selective toxicity of this isocarbostyril to cancer cells. Thus, pancratistatin was found to selectively induce apoptosis using non-genomic targets in Jurkat (model for human T-cell leukemia) cell line as opposed to normal nucleated blood cells.…”
Section: Anticancer Activitiesmentioning
confidence: 99%
“…Removal of the oxygen substituents on ring A leads to significant reduction of potency. 7-Deoxypancratistatin is about 10-fold less potent, 27 while analogue 1 (Fig. 2) with a single alkoxy group, prepared by Hudlicky and coworkers, 28 is 100-fold less cytotoxic than pancratistatin.…”
Section: Introduction and Biomedical Significancementioning
confidence: 97%
“…For example, both 7 and 8 were about 10 times more potent than their 7-deoxy analogues ( 5 and 6 ) against the prostate DU-145 cells, and this 10-fold difference in activity is similar to that between 1 and 3 . 2a,13b In addition, the double-digit nanomolar potency of the acetoxymethyl analogue ( 8 ) is noteworthy and it approaches that of narciclasine, which was used as a reference compound. The most encouraging activity was found, however, with the benzoxymethyl compound ( 9 ).…”
Section: Resultsmentioning
confidence: 99%
“…In our group, we have been investigating various truncated derivatives of pancratistatin, and 7-deoxypancratistatin, 12 as well as derivatives with variations of functionality at the aromatic core, 13 including an indole mimic of 7-deoxypancratistatin. 14 More recently, and inspired by Pettit's report of the C-1 benzoate ester, 4c we investigated carbon homologues of 7-deoxypancratistatin at position C-1 and found that the hydroxymethyl and acetoxymethyl derivatives ( 5 and 6 , respectively) were reasonably active.…”
Section: Introductionmentioning
confidence: 99%